Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06354582
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-03-26
Brief Title:
Effect of Intravenous Vitamin C on Intrapartum Maternal Fever After Epidural Labor Analgesia
Sponsor:
Kunyue Li
Organization:
Third Affiliated Hospital of Zhengzhou University
Study Overview
Official Title:
Effect of Intravenous Vitamin C on Intrapartum Maternal Fever After Epidural Labor Analgesia A Randomized Controlled Trial
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EIVCIMFAELA
Brief Summary:
This study aims to explore the effect of intravenous vitamin C infusion on intrapartum fever after epidural labor analgesia to reduce the impact of intrapartum fever on maternal and infant improve maternal and infant outcomes and provide a reference for clinical preventive medication
Detailed Description:
Parturients who request pain relief would receive epidural labor analgesia after the obstetrician and anesthesiologist jointly evaluated and approved The epidural catheter was inserted at the intervertebral space of either L2-3 or L3-4 5 ml 15 chloroprocaine with 1200000 epinephrine as a test was delivered to parturients via the catheter Then parturients would be observed for 5 min whether there were adverse reactions and then were given an initial dose of 10 ml ropivacaine 008 with sufentanil 03 µgml After that a patient-controlled epidural analgesia PCEA pump 240ml 008 ropivacaine with sufentanil 03 µgml would be attached to the catheter The pump would be set to administer an 8 ml bolus every 20 minutes and a 2 ml patient-controlled bolus with the same interval Subsequently trained nursing staff would take charge of the parturients and inform the obstetrician The basic condition of parturients was monitored during the whole process After that parturients in each group will be administered vitamin C intravenously except the group for placebo-controlled
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None